Skip to main content

Melissa Weiss, Associate Editor

Melissa Weiss, Associate Editor
Jesse Veenstra, MD, PhD, discussed the findings from the recent Henry Ford Health System study on the risk of COVID-19 infection and severe outcomes among patients with immune-mediated inflammatory diseases treated with immunosuppressive therapies.
Melissa Weiss, Associate Editor
A recent study highlighted several common patient-reported symptoms of hidradenitis suppurativa flares, including pain and drainage. In an interview with The Dermatologist, study authors Jennifer M. Fernandez, RD, and Vivian Shi, MD, discussed these findings and their implications for clinical practice.
Melissa Weiss, Associate Editor
The following is an excerpt from Pearls in Psoriasis with Dr Lawrence Green, featuring Dr April Armstrong and her study on patient mental health and satisfaction with their physicians.
Melissa Weiss, Associate Editor
A new large-scale study is underway to assess the impact of systemic therapies on COVID-19 among patients with atopic dermatitis and psoriasis. Dr Emma Guttman discusses the goals of the study and how it could help shape COVID-19 treatment among patients with inflammatory skin diseases.
Melissa Weiss, Associate Editor
Findings from a recent study showed tape strips may be a minimally invasive alternative to skin biopsies. Emma Guttman, MD, PhD, discussed these findings and their implications for clinical trials and practice.
Melissa Weiss, Associate Editor
When it comes to dermatology fellowship programs, accessible information may be the difference between candidates applying or not applying to their perfect “match.” Chapman Wei, BS, and Adam Friedman, MD, FAAD, discuss the importance of dermatology programs updating their websites to include more thorough descriptions and information regarding their programs, especially in the context of the current pandemic.
Melissa Weiss, Associate Editor
The following is an excerpt from our latest podcast with Dr Jonathan Silverberg on the rise and fall of hydroxychloroquine as a “wonder drug” for COVID-19 and the importance of evidence-based medicine.
Melissa Weiss, Associate Editor
Findings from a recent study showed spironolactone was not associated with an increased risk of breast cancer recurrence among survivors of breast cancer. Dr Adam Friedman discussed these results in an interview with The Dermatologist.
Melissa Weiss, Associate Editor
Photoprotection is an integral part of skin care for all patients, but the established clinical evidence was mostly based on lower Fitzpatrick skin types. Dr Qian Zheng shared insights on the long-term benefits of proper daily sunscreen use in a Hispanic population with phototypes IV and V.
Melissa Weiss, Associate Editor
While the upper respiratory tract symptoms of the novel SARS-CoV-2 virus are widely recognized, new reports are suggesting possible skin manifestations among patients with the COVID-19. In an interview with The Dermatologist, Esther Freeman, MD, PhD, principle investigator, discussed the COVID-19 Dermatology registry in collaboration with the American Academy of Dermatology (AAD) and what the AAD hope to learn from providers across disciplines who are submitting cases.
Back to Top